Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Serine-aspartate repeat-containing protein G (SdrG) is a cell-surface adhesin found in certain Gram-positive bacteria such as *Staphylococcus epidermidis* and *Staphylococcus aureus*. It plays a key role in bacterial pathogenesis by binding specifically to the N-terminal region of the B beta-chain of human fibrinogen. This interaction interferes with thrombin-mediated cleavage and release of fibrinopeptide B from fibrinogen. SdrG also mediates weak homophilic bonds between bacterial cells that facilitate biofilm formation on surfaces such as indwelling medical devices. These properties make it an important virulence factor contributing to infection persistence and immune evasion. Experimental studies have shown that peptides derived from β-neurexin can inhibit SdrG-mediated adhesion and biofilm accumulation[5][7].
Binds to the N-terminal region of the B beta-chain of human fibrinogen, interfering with thrombin cleavage and release of fibrinopeptide B. Mediates homophilic interactions that promote cell–cell adhesion in biofilms. Can be inhibited by peptides derived from β-neurexin that block its adhesive functions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serine-aspartate repeat-containing protein G (SdrG).